new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline

May 2011

Please see the November 2011 FDA statement concerning Makena.

You'll see new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline.

One in eight babies is born prematurely in the United States.

Makena (mah-KEE-na) is the first drug APPROVED for reducing the risk of preterm birth...but it's not really new.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Infectious Diseases shift in quinolone use as generic levofloxacin (Levaquin) becomes available in June
Antithrombotics Patients can now keep Pradaxa (dabigatran) for 60 days after the bottle is opened
Antithrombotics whether patients should stop anticoagulant or antiplatelet meds before dental procedures
Allergic Reactions true allergy to iodine is a medical myth
Vaccines YOUNGER patients are now eligible for Zostavax to prevent shingles
Women's Health when to use metformin or pioglitazone for polycystic ovary syndrome (PCOS)
Women's Health new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline
Psychiatry systemic corticosteroids can cause adverse CNS effects
Asthma children getting inhaled corticosteroids PRN for MILD persistent asthma
Oral Health warning about the use of OTC oral benzocaine gels or liquids (Anbesol, Orajel, etc) in children under age 2
Oral Health Xerese (zuh-REES), a new Rx topical product for cold sores (herpes simplex labialis)
Lupus new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab)
Neurology & Pain new risk management programs with Abstral (AB-stral) and other immediate-release fentanyl products